Premium
KINASE‐DEAD BRUTON’S TYROSINE KINASE (BTK) C481F/Y MUTANTS CONFER IBRUTINIB RESISTANCE THROUGH ACTIVATION OF HEMATOPOIETIC CELL KINASE (HCK)
Author(s) -
Dhami K.,
Cheung L. W.K.,
Sun C.,
DeAnda F.,
Huang X.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.55_2880
Subject(s) - bruton's tyrosine kinase , ibrutinib , tyrosine kinase , breakpoint cluster region , cancer research , b cell receptor , lyn , kinase , signal transduction , microbiology and biotechnology , biology , b cell , biochemistry , receptor , chronic lymphocytic leukemia , immunology , leukemia , antibody
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom